Table 1
Planned Week 24 Interim Analysis Results | S/GSK1349572 10 mg (n=53) | S/GSK1349572 25mg (n=51) | S/GSK1349572 50mg (n=51) | EFV control (n=50) |
|---|---|---|---|---|
Mean baseline HIV-1 RNA (log10 c/mL) | 4.42 | 4.38 | 4.58 | 4.46 |
%<50c/mL at 24 wks (by TLOVR) | 96% (51/53) | 90% (46/51) | 92% (47/51) | 78% (39/50) |
Median baseline (change from baseline at 24 weeks) CD4+ cells/mm3 | 289 (+159) | 330 (+206) | 305 (+167) | 308 (+110)† |